-
Mashup Score: 582
Background The relationship of host immune response and viral replication with health outcomes in patients with COVID-19 remains to be defined. We aimed to characterize the medium and long-term clinical, virological, and serological outcomes after hospitalization for COVID-19, and to identify predictors of long-COVID. Methods Prospective, longitudinal study conducted in COVID-19 patients…
Source: Journal of Clinical ImmunologyCategories: Latest Headlines, NursingTweet
-
Mashup Score: 423
Background The relationship of host immune response and viral replication with health outcomes in patients with COVID-19 remains to be defined. We aimed to characterize the medium and long-term clinical, virological, and serological outcomes after hospitalization for COVID-19, and to identify predictors of long-COVID. Methods Prospective, longitudinal study conducted in COVID-19 patients…
Source: Journal of Clinical ImmunologyCategories: Cardiologists, Latest HeadlinesTweet-
RT @Dr2NisreenAlwan: Here we have it. #LongCovid is linked to lower antibody response. https://t.co/L4QZbORjAR
-
RT @Dr2NisreenAlwan: Here we have it. #LongCovid is linked to lower antibody response. https://t.co/L4QZbORjAR
-
-
Mashup Score: 0Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy - 3 year(s) ago
To the Editor,The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. In most cases, COVID-19 is a self-limited infection but some patients will present with severe respiratory distress requiring intensive care unit admission and mechanical ventilation. The main risk factors for…
Source: Journal of Clinical ImmunologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy [Nov 20, 2020] London et al. J Clin Immunol https://t.co/XZboOedeDs #2019nCoV #COVID19 HT @DrMJoyner
-
-
Mashup Score: 0Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy - 3 year(s) ago
To the Editor,The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. In most cases, COVID-19 is a self-limited infection but some patients will present with severe respiratory distress requiring intensive care unit admission and mechanical ventilation. The main risk factors for…
Source: Journal of Clinical ImmunologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy [Nov 20, 2020] London et al. J Clin Immunol https://t.co/XZboOedeDs #2019nCoV #COVID19 HT @DrMJoyner
-
-
Mashup Score: 2Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β - 3 year(s) ago
References1.NIH. Clinical spectrum of SARS-CoV-2 infection December 17, 2020 [Available from: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/.2.Johns Hopkins University & Medicine CRC. https://coronavirus.jhu.edu/map.html 2021 [3.Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening…
Source: Journal of Clinical ImmunologyCategories: Latest Headlines, RheumatologyTweet-
RT @LCalabreseDO: Excellent position on pros/cons of IFN Rx (and JAKi & other Rx) https://t.co/UU2sGAlcCA in #COVID19 - @JYazdanyMD @CCalab…
-
-
Mashup Score: 0Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy - 3 year(s) ago
To the Editor,The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. In most cases, COVID-19 is a self-limited…
Source: Journal of Clinical ImmunologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy [Nov 20, 2020] London et al. J Clin Immunol https://t.co/XZboOedeDs #2019nCoV #COVID19 HT @DrMJoyner
-
-
Mashup Score: 0Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy - 3 year(s) ago
To the Editor,The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. In most cases, COVID-19 is a self-limited…
Source: Journal of Clinical ImmunologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy [Nov 20, 2020] London et al. J Clin Immunol https://t.co/XZboOedeDs #2019nCoV #COVID19 HT @DrMJoyner
-
-
Mashup Score: 2Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy - 3 year(s) ago
To the Editor,The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. In most cases, COVID-19 is a self-limited…
Source: Journal of Clinical ImmunologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy [Nov 20, 2020] London et al. J Clin Immunol https://t.co/XZboOedeDs #2019nCoV #COVID19 HT @DrMJoyner
-
-
Mashup Score: 1BCG-Related Inflammatory Syndromes in Severe Combined Immunodeficiency After TCRαβ+/CD19+ Depleted HSCT - 4 year(s) ago
The live-attenuated BCG vaccine is known to cause disseminated Mycobacterium bovis infection in patients with severe combined immunodeficiency (SCID). However, BCG-related post-hematopoietic stem cell transplantation (HSCT) immune reconstitution inflammatory syndromes, similar to those described in patients with HIV infections, are less-known complications of SCID. We reported on 22…
Source: Journal of Clinical ImmunologyCategories: Hem/Oncs, Latest HeadlinesTweet-
BCG-Related Inflammatory Syndromes in Severe Combined Immunodeficiency After TCRαβ+/CD19+ Depleted HSCT https://t.co/K7UQgLyYdq
-
RT @Dr2NisreenAlwan: Here we have it. #LongCovid is linked to lower antibody response. https://t.co/L4QZbORjAR